Sep 11, 2024

Public workspaceRSVAB WGS and GF protocols V.4

  • 1Laboratory of Reference and Research in Respiratory Viruses, National Centre for Microbiology, Instituto de Salud Carlos III, 28220 Majadahonda, Spain
Icon indicating open access to content
QR code linking to this content
Protocol CitationMaria Iglesias 2024. RSVAB WGS and GF protocols. protocols.io https://dx.doi.org/10.17504/protocols.io.kqdg3xbzqg25/v4Version created by Maria Iglesias
Manuscript citation:
Generic novel system for genomic characterization of Respiratory Syncytial Virus obtaining whole genome sequencing and a full-length G and F sequences.
License: This is an open access protocol distributed under the terms of the Creative Commons Attribution License,  which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Protocol status: Working
We use this protocol and it's working
Created: December 14, 2023
Last Modified: September 11, 2024
Protocol Integer ID: 107340
Abstract
This SOP describes the procedure for generating cDNA from RSV viral nucleic acid extracts and subsequently producing amplicons tiling the viral genome using. We propose two systems for genomic characterization of RSV. First, a novel RSV amplicon-based system for WGS, and second, a method focused on obtaining the specific sequences of the main antigens, G and F.
Sample management
Sample management
No prior treatment is necessary. However, in samples with high Cts, the use of DNAseI in the sample as a pretreatment can improve coverage.
dsCDNA generation:
dsCDNA generation:
During this step three master mixes will be prepared: MMI, MMII and MMIII.
Materials: Kit Superscript III First Strand (Invitrogen)
100% DMSO
RNAseH (Invitrogen)
Klenow fragment 3' ->5' exo (New England Biolabs)
Primer FR26RV-N : 5’GCC GGA GCT CTG CAG ATA TCNNNNNN 3’


Note
This step must be performed in a RNase free, pre-PCR environment in which post PCR RSV amplicons are not present, to minimise risk of sample contamination.

CITATION
Díez-Fuertes F, Iglesias-Caballero M, García-Pérez J, Monzón S, Jiménez P, Varona S, Cuesta I, Zaballos Á, Jiménez M, Checa L, Pozo F, Pérez-Olmeda M, Thomson MM, Alcamí J, Casas I (2021). A Founder Effect Led Early SARS-CoV-2 Transmission in Spain..


MMI Preparation:

AB
FR26RV-N (10uM)2
DMSO0,5
Total2,5 ul
Mix thoroughly by vortexing.
MMII Preparation:

AB
10x First Strand Buffer2
DTT 100 mM2
MgCl2 25mM4
dNTPs1
RNaseOUT0,5
SSIII RT0,5
Total10 ul
Kit Superscript III First Strand (Invitrogen)


MMIII Preparation:

AB
Klenow 5'-3'1
RNAseH0,5
Total1,5 ul

Defrost extracted RNA.

Maintain on ice the MMI,MMII and MMIII mixes.

MMI Amplification:
Add Amount5 µL SampleSample in MMI mix

Place the tube on a thermocycler and run the following program:


AB
65ºC5 min
4ºC2 min

Briefly tube centrifugation
MMII Amplification:
Addition of Amount10 µL from MMII in the tube with the MMI and the viral extraction.

Place the tube on a thermocycler and run the following program:

AB
25ºC10 min
50ºC50 min
85ºC10 min
4ºC

Briefly tube centrifugation
MMIII Amplification:
Addition of Amount1.5 µL of MMIII into the tube with the previous mixes and the viral extraction

Place the tube on a thermocycler and run the following program:

AB
37ºC60 min
75ºC15 min

Briefly tube centrifugation
STOP POINT: cDNA can be stored at 4°C (same day) or -20°C (up to a week).
RSVAB WGS protocol
RSVAB WGS protocol

CITATION
Iglesias-Caballero M, Camarero-Serrano S, Varona S, Mas V, Calvo C, García ML, García-Costa J, Vázquez-Morón S, Monzón S, Campoy A, Cuesta I, Pozo F, Casas I (2023). Genomic characterisation of respiratory syncytial virus: a novel system for whole genome sequencing and full-length G and F gene sequences..

Materials:
2x MyTaqRed mix (Bioline)
Primers:
AB
Primer ID Sequence (5’-3’)
Mix 1
RSVCombinitial ACGCGAAAAAATGCGTACWACA
RSVWGS1R.2 GCKATTGCAGATCCWACACC
RSVWGS2FCACTWACAATATGGGTGCC
RSVWGS2R.2CRTTYCTTAARGTRGGCC
RSVWGS4R CATGWTGWYTTATTTGCCCC
RSVWGS3.2F ACATGGAAAGAYATYAGCC
RSVWGS3.2R TTGCATCTGTAGCAGGAATGG
RSVWGS9FGARCAACTCAAAGAAAATGG
RSVWGS9RAYTGRAACATRGGCACCC
RSVCombending ACGAGAAAAAAAGTGTCAAAAACTAA
Mix 2
RSVCombinitial ACGCGAAAAAATGCGTACWACA
RSVWGS1R.2AYTGRAACATRGGCACCC
RSVWGS5F CATAATTAYTTTGAATGGC
RSVWGS5R CAAACATTTAATCTRCTAAGGC
RSVWGS6F TTATAYAGATATCAYATGGGTGG
RSVWGS6R CCCTCTCCCCAATCTTTTTC
RSVWGS13FAAAAGATTGGGGAGAGGG
RSV OG1_21GGGGCAAATGCAACCATGTCC
RSV GF_RTTCGYGACATATTTGCCCC
RSVCombending ACGAGAAAAAAAGTGTCAAAAACTAA

ABCDEFG
1EPI_ISL_18668201 -13RSVCombinitial1 +
2EPI_ISL_1866820121932212RSVWGS9F1 +
3EPI_ISL_1866820123212340RSVWGS4R2 -
4EPI_ISL_1866820133373355RSVWGS_2F1 +
5EPI_ISL_1866820133493366RSVWGS9R2 -
6EPI_ISL_1866820146564676OG1211 +
7EPI_ISL_1866820161236142RSVWGS_1R.22 -
8EPI_ISL_1866820176477665RSVGF-R2 -
9EPI_ISL_1866820177127730RSVWGS_5F1 +
10EPI_ISL_1866820193749395RSVWGS_5R2 -
11EPI_ISL_1866820193589376RSVWGS_3.2F1 +
12EPI_ISL_18668201998610003RSVWGS_2R.22 -
13EPI_ISL_186682011085210874RSVWGS_6F1 +
14EPI_ISL_186682011307613093RSVWGS_13F1 +
15EPI_ISL_186682011309013109RSVWGS_6R2 -
16EPI_ISL_186682011426714287RSVWGS_3.2R2 -
17EPI_ISL_186682011520015225RSVCombEnding2 -
1EPI_ISL_1653999122RSVCombinitial1 +
2EPI_ISL_165399921592178RSVWGS9F1 +
3EPI_ISL_165399922882307RSVWGS4R2 -
4EPI_ISL_165399933113329RSVWGS_2F1 +
5EPI_ISL_165399933233340RSVWGS9R2 -
6EPI_ISL_165399946314651OG1211 +
7EPI_ISL_165399961026121RSVWGS_1R.22 -
8EPI_ISL_165399976187636RSVGF-R2 -
9EPI_ISL_165399976997717RSVWGS_5F1 +
10EPI_ISL_165399993449365RSVWGS_5R2 -
11EPI_ISL_165399993289346RSVWGS_3.2F1 +
12EPI_ISL_165399999569973RSVWGS_2R.22 -
13EPI_ISL_16539991082210844RSVWGS_6F1 +
14EPI_ISL_16539991306213079RSVWGS_13F1 +
15EPI_ISL_16539991306013059RSVWGS_6R2 -
16EPI_ISL_16539991423714257RSVWGS_3.2R2 -
17EPI_ISL_16539991520915222RSVCombEnding2 -
Primer scheme with RSVA and RSVB RefSeq

Note
The protocol is based in the RSV genome amplification in two separate mixes with an unique amplification program. The mixes that will be mixed at the end of cycling.

..2Preparation of RSV Amplification Mix 1:

AB
MyTaq Red 2x15
H208,4
RSV Combinitial (5 uM)0,2
RSVWGS1R2.2 (5uM)0,2
RSVWGS2F (5 uM)0,2
RSVWGSW2R.2 (5 uM)0,2
RSVWGS4R (5 uM)0,2
RSVWGS3.2F (5 uM)0,2
RSVWGS3.2R (5 uM)0,2
RSVWGS9F (5uM)0,2
RSVWGS9R (5 uM)0,2
RSV Combending (5uM)0,2
Total25

Preparation of RSV Amplification Mix 2:

AB
2x My Taq Red15
H2O7,6
RSV Combinitial (5uM)0,2
RSVWGS1R.2 (5 uM)0,2
RSVWGS5F (5 uM)0,2
RSVWGS5R (5 uM)0,2
RSVWGS6F (5 uM)0,2
RSVWGS6R (5 uM)0,2
RSVWGS9F (5 uM)0,2
RSVWGS9R (5 uM)0,2
RSVWGS13F (5 uM)0,2
RSV OG1_21 (5 uM)0,2
RSV GF_R (5 uM)0,2
RSV Combending (5 uM)0,2
Total25 ul

Addition of Amount5 µL of the previous prepared double stranded cDNA on each mix.

Amplification protocol:

ABC
95ºC1 min
95ºC30 segx45
55ºC8 min
72ºC2 min
72ºC5 min
12ºC

To assess PCR performance, the amplicons can be loaded onto a 1% agarose gel for electrophoresis.



Finally, mix in one single tube both mixes and proceed to purification and library preparation.
RSVAB GF protocol starting from ds cDNA
RSVAB GF protocol starting from ds cDNA
Due to the significance of achieving accurate RSV genomic characterization, it was developed the RSVAB-GF PCR to complement the genomic coverage of both antigenic major proteins in cases where WGS encounters difficulties, and to provide a simpler and more cost-effective method of obtaining the sequences of both antigens.
Materials:
2x MyTaqRed mix (Bioline)
Primers:

AB
OG1-21GGGGCAAATGCAACCATGTCC
RSVGF-RTTCGYGACATATTTGCCCC

Preparation of cDNA GF amplification mix:


AB
H205,5
2X MyTaqRed12,5
OG1-21 (10 uM)1
RSVGF-R (10 uM)1
Total20 ul

Addition of Amount5 µL of the previous prepared double stranded cDNA on the mix.
Amplification protocol cDNA GF:

ABC
95ºC1 min
95ºC30 segx35
60ºC3 min
72ºC2 min
72ºC5 min
12 ºC

RSVAB GF protocol starting from viral extraction
RSVAB GF protocol starting from viral extraction
Materials:
Qiagen OneStep RT-PCR kit.
Glycerolised 1% H20

Preparation of GF amplification mix:
AB
H20gly10
5xQ PCR MM6
dNTPs1
OG1-21 (10uM)1
RSVGF-R (10 uM)1
RT-PCR mix1
Total20 ul

Addition of Amount10 µL of the viral extraction
Amplification protocol GF:

ABC
48ºC60 min
95ºC15 min
95ºC30 segx 35
60ºC3 min
72ºC2 min
72ºC5 min
12ºC

Citations
Step 11
Iglesias-Caballero M, Camarero-Serrano S, Varona S, Mas V, Calvo C, García ML, García-Costa J, Vázquez-Morón S, Monzón S, Campoy A, Cuesta I, Pozo F, Casas I. Genomic characterisation of respiratory syncytial virus: a novel system for whole genome sequencing and full-length G and F gene sequences.
https://doi.org/10.2807/1560-7917.ES.2023.28.49.2300637
Step 2
Díez-Fuertes F, Iglesias-Caballero M, García-Pérez J, Monzón S, Jiménez P, Varona S, Cuesta I, Zaballos Á, Jiménez M, Checa L, Pozo F, Pérez-Olmeda M, Thomson MM, Alcamí J, Casas I. A Founder Effect Led Early SARS-CoV-2 Transmission in Spain.
https://doi.org/10.1128/JVI.01583-20